Injective introduces iNVDA, the first on-chain Nvidia stock, enabling 24/7 trading and programmable finance on its blockchain.
Author: Tanishq Bodh
Injective, a blockchain built for decentralized finance, has launched the first on-chain Nvidia stock, known as iNVDA, on its mainnet. This move enables 24/7 trading, leverage, and programmability, marking a significant step toward integrating traditional financial assets into the blockchain ecosystem.
With Nvidia ($NVDA) among the world’s largest companies, its selection as the first iAsset signals Injective’s broader ambition: making trillion-dollar financial markets accessible through decentralized finance (DeFi).
Injective has previously experimented with on-chain stock trading, introducing Tesla and GameStop stocks on its Solstice testnet in 2021, well before the real-world asset (RWA) tokenization trend gained traction. Additionally, the platform has facilitated gold and silver tokenization, pushing the boundaries of DeFi’s role in traditional markets.
Injective’s iAssets allow stocks, bonds, and ETFs to function as programmable, composable financial instruments rather than just passive, tokenized representations. Unlike traditional financial markets, these instruments offer:
Injective plans to accelerate on-chain stock, bond, and ETF integration in the coming months, aiming to reshape financial markets through decentralization. This initiative aligns with the broader push toward tokenized traditional finance, allowing investors to engage with stocks like Nvidia in a permissionless, DeFi-driven environment.
For crypto and traditional investors alike, Injective’s iNVDA offers exposure to Nvidia stock without relying on centralized brokers. However, regulatory uncertainties and market adoption will play key roles in determining the success of on-chain stocks in DeFi.
Our Crypto Talk is committed to unbiased, transparent, and true reporting to the best of our knowledge. This news article aims to provide accurate information in a timely manner. However, we advise the readers to verify facts independently and consult a professional before making any decisions based on the content since our sources could be wrong too. Check our Terms and conditions for more info.
